Botulinum neurotoxin therapy in the clinical management of laryngeal dystonia

HIGHLIGHTS

  • who: Winnie Yeung et al. from the Voice Research Laboratory, Faculty of Medicine and Health, University of Sydney have published the paper: Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia, in the Journal: Toxins 2022, 844 of 28/Nov/2022
  • future: InIn cases of needle position before delivery BoNT. caseswhere wherethe theLCA LCAmuscle muscleisistargeted targeted aa similar approach is deployed with the needle angled more posterolateral. similar approach is deployed with the needle angled more posterolateral.

SUMMARY

    Adverse Effects and Development of Resistance to BoNT-A Whilst considered a . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?